By Keith L. Carson
Volume 13, Issue 4 (Winter 2014/2015)
Thankfully, recent market fluctuations have made M&As less attractive, and we can see more firms committed to building the businesses they already have, and developing strategic partners instead of acquisition targets. For this issue, I want to address the developments that may mean we are entering some lofty times in the biotech industry…
Citation: Carson KL. From the Editor-in-Chief: Building Businesses and Developing Strategic Partnerships. BioProcess J, 2014; 13(4): 5. https://doi.org/10.12665/J134.Carson
Posted online July 27, 2026